Wang et al. demonstrated that NF-κB can regulate EGF-induced EMT and cancer metastasis, but NF-κB inhibitors could block EGF-induced EMT, and suppress the invasion and migration of TSCC [8]. The gene discussed is NFKB1; the disease is cancer.